Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Marinomed Biotech AG sell ReynadJ

Start price
€11.70
27.04.25 / 0%
Target price
€2.00
27.04.26
Performance (%)
38.89%
End price
€16.25
10.03.26
Summary
This prediction ended on 10.03.26 with a price of €16.25. The SELL prediction by ReynadJ for Marinomed Biotech AG was trending in the completely wrong direction and closed with a performance of 38.89%. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.
Performance without dividends (%)
Name 1w 1m
Marinomed Biotech AG - -
iShares Core DAX® -4,93 % -11,98 %
iShares Nasdaq 100 -2,63 % -2,22 %
iShares Nikkei 225® -4,73 % -10,90 %
iShares S&P 500 -2,54 % -3,54 %

According to ReynadJ what are the pros and cons of Marinomed Biotech AG for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Low dividend yield expected
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
ROE lower than 10% per year
Increased challenges to pay loans and raise capital

Comments by ReynadJ for this prediction

In the thread Marinomed Biotech AG diskutieren

Sell Marinomed Biotech AG

Prediction Sell
Perf. (%) 38.89%
Target price 2.000
Change
Ends at 27.04.26

Kursziel gesetzt auf 2,0